Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22759,175,1.58 [1.05-2.38],0.0293954984383045
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23803,190,1.13 [0.76-1.67],0.5448835372915668
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23555,1414,1.13 [0.98-1.30],0.1052690995144251
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Candidiasis,23814,381,1.01 [0.76-1.33],0.94363831476908
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23122,3481,1.07 [0.97-1.17],0.1824588469965301
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23076,3505,1.10 [1.00-1.21],0.0490877737362914
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23600,1048,1.11 [0.94-1.32],0.2252318922540266
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23736,80,1.49 [0.81-2.72],0.1984442145744439
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21583,1129,1.06 [0.90-1.25],0.5176563125103074
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,20827,1247,1.23 [1.05-1.44],0.0089326363200032
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,20539,253,1.34 [0.95-1.90],0.0953040558670407
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16759,2285,1.02 [0.91-1.15],0.6831096013526927
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20471,407,1.61 [1.22-2.11],0.0006783160929773
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23805,1253,1.09 [0.93-1.27],0.2769971306345071
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,23905,472,1.10 [0.85-1.41],0.466519141600454
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23035,894,1.17 [0.97-1.40],0.0945302459220677
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23826,1242,1.07 [0.91-1.25],0.4039372716721597
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22744,192,1.07 [0.72-1.59],0.7227059801020128
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23944,54,1.83 [0.88-3.81],0.1079595787900166
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,23672,1088,1.00 [0.85-1.18],0.990866129355638
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23727,71,0.87 [0.45-1.65],0.6634808674491295
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,23881,120,1.69 [1.03-2.78],0.0373851710289053
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23862,101,1.87 [1.09-3.22],0.0230677846151975
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22636,495,1.05 [0.82-1.34],0.6838792513437248
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22428,287,1.23 [0.89-1.69],0.2182637179588027
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22641,89,1.23 [0.69-2.20],0.4772201981459176
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23925,68,1.08 [0.56-2.09],0.8148498772912238
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23890,146,1.22 [0.77-1.91],0.3960844243635066
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral warts,23797,53,1.77 [0.84-3.73],0.1315717822902213
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23796,52,1.57 [0.74-3.33],0.2383492848082525
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,23626,343,0.86 [0.64-1.16],0.3259611113433407
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23872,44,0.32 [0.14-0.73],0.0070428828803478
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23837,55,0.83 [0.39-1.75],0.621316215157125
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of spermatic cord,23896,129,0.85 [0.52-1.38],0.5103634763755309
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23568,1647,0.78 [0.68-0.89],0.0002621019152887
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of meninges,23944,32,0.35 [0.13-0.92],0.0331844544051049
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23880,63,2.35 [1.20-4.61],0.0128694505661847
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23929,76,1.32 [0.71-2.46],0.3787838025144794
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Ascending colon,23919,443,0.69 [0.53-0.89],0.004946693494886
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Caecum,23914,340,0.73 [0.54-0.98],0.0346468541592294
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23812,81,1.12 [0.61-2.05],0.7066055024752951
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Descending colon,23912,279,0.64 [0.46-0.88],0.0067683610196903
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,23870,421,0.73 [0.56-0.95],0.02116351031948
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23820,731,0.72 [0.59-0.89],0.0018601695222411
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Transverse colon,23901,561,0.71 [0.56-0.89],0.0030480131452018
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",18597,71,1.88 [0.99-3.59],0.054193704435947
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",18597,71,0.66 [0.34-1.27],0.2104746740654381
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23912,100,0.71 [0.41-1.23],0.2241075900638493
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",23912,97,0.69 [0.40-1.21],0.1962342375262515
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lung cancer and mesothelioma,15937,344,0.52 [0.38-0.70],2.283899990015208e-05
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Lymphoid leukaemia,18591,65,1.63 [0.83-3.20],0.1596676719968103
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",18728,202,1.07 [0.72-1.58],0.737996071404156
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",18821,295,0.95 [0.69-1.31],0.7658024802251788
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",18617,91,1.67 [0.95-2.92],0.0742496293649471
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",18669,143,1.22 [0.77-1.93],0.391764137239307
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",18664,138,1.01 [0.64-1.61],0.9578005374350336
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",18608,82,0.78 [0.43-1.44],0.4315706060772937
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",19932,1406,1.01 [0.87-1.17],0.9236278127326792
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",18670,144,0.95 [0.60-1.51],0.8290580655356978
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",18632,106,1.14 [0.67-1.94],0.6266617149523561
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,18657,131,1.60 [0.99-2.59],0.0563269269305719
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,23817,169,1.01 [0.66-1.54],0.9791879369693922
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of trunk,23913,93,0.89 [0.50-1.58],0.6911932813297723
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanoma in situ,18561,75,0.63 [0.33-1.21],0.1652241002634774
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",18627,101,0.73 [0.42-1.27],0.2639957676834845
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",18697,171,0.84 [0.55-1.29],0.431744890034646
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",18745,219,0.45 [0.31-0.65],2.704660587268121e-05
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",18630,104,1.15 [0.67-1.98],0.6039404936583614
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,23810,138,0.73 [0.46-1.16],0.1827232911428186
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19741,1215,0.93 [0.79-1.09],0.3613223372213553
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19819,1293,0.95 [0.81-1.11],0.4958509136902241
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23669,311,0.59 [0.44-0.81],0.0011120102029449
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,22199,119,6.54 [4.05-10.57],1.810732921468549e-14
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,23430,72,0.95 [0.50-1.81],0.87851942272773
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23382,2796,1.08 [0.97-1.19],0.1663022576907225
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22663,61,1.12 [0.55-2.26],0.7558519372339684
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23515,54,0.61 [0.29-1.29],0.1949331129142375
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,23564,1484,1.16 [1.00-1.33],0.0440238385005535
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,23562,1482,1.16 [1.01-1.34],0.0387682426085435
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,22185,105,1.63 [0.95-2.78],0.0751518291633993
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23706,1104,1.26 [1.07-1.48],0.0061240659519342
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23567,106,1.49 [0.88-2.53],0.1384694145472437
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,23434,76,1.38 [0.74-2.58],0.3090046660162192
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,23418,60,1.29 [0.64-2.62],0.4739091918875439
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23779,318,0.94 [0.69-1.27],0.6826639628472914
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23847,49,0.97 [0.44-2.13],0.9384242500948728
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23719,258,1.05 [0.75-1.48],0.7626696417390111
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22680,78,0.75 [0.40-1.40],0.3729652918283646
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,17647,375,1.30 [0.97-1.73],0.0745798098712534
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,21894,165,0.33 [0.22-0.51],5.414231708200945e-07
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,21922,193,0.31 [0.20-0.45],5.696959627524393e-09
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,17329,57,0.56 [0.27-1.19],0.1350453107389755
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,22563,65,0.86 [0.43-1.69],0.653906104606951
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21798,222,0.56 [0.39-0.81],0.0024341650544185
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23438,617,1.35 [1.08-1.68],0.0072393170294498
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,23062,241,1.22 [0.86-1.74],0.2703796757678651
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22989,168,0.77 [0.50-1.18],0.2293912869442586
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23641,1143,0.85 [0.72-1.00],0.0521658371009866
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20486,1101,0.81 [0.69-0.96],0.0133870019867606
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",17347,75,1.12 [0.59-2.14],0.723754119587146
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",23064,40,0.98 [0.41-2.33],0.9669773938971096
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,17549,277,1.28 [0.91-1.79],0.1512252592681302
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,17347,75,1.20 [0.63-2.30],0.5844220406882413
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21169,3897,0.87 [0.80-0.95],0.0026601811740076
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,17458,186,0.68 [0.45-1.03],0.0658837530617247
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,17846,574,0.97 [0.77-1.22],0.7893646868791608
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23885,278,1.88 [1.36-2.60],0.0001340710999293
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23698,91,5.50 [3.19-9.47],8.498939288315621e-10
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,17427,155,0.91 [0.58-1.43],0.6741910721642037
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",17337,65,2.12 [1.07-4.21],0.0317781805486943
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,23765,741,1.13 [0.92-1.38],0.2390277339489144
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,17578,306,1.56 [1.14-2.13],0.0057728340375884
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,17652,380,1.83 [1.38-2.43],2.639144023022897e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",18002,730,0.91 [0.74-1.12],0.3552601178702556
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,17417,145,1.52 [0.96-2.40],0.0775820222856366
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23691,84,6.48 [3.70-11.35],6.210967219435978e-11
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,17839,567,0.96 [0.76-1.22],0.7520119385012609
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,17665,393,0.63 [0.47-0.83],0.0010244581200099
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21643,67,2.10 [1.09-4.07],0.027483337444944
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22497,5225,0.89 [0.83-0.97],0.0041798272223939
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,23043,19,5.25 [1.63-16.97],0.0055379053885541
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,23046,22,3.06 [0.98-9.54],0.05335041177517
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23774,1780,0.89 [0.78-1.02],0.0836146428833611
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23771,1776,0.89 [0.78-1.01],0.0732913627974949
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,23047,23,2.09 [0.68-6.38],0.195629503327373
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23672,803,0.84 [0.70-1.03],0.0901109409993146
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",18893,1621,1.04 [0.90-1.19],0.6197299911668885
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23933,266,3.62 [2.64-4.96],1.4885124961473914e-15
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22930,109,1.09 [0.65-1.85],0.741721417121033
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,22944,75,0.86 [0.46-1.62],0.646623461593584
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,22950,81,1.15 [0.63-2.11],0.6444296189632073
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",17338,66,0.86 [0.43-1.71],0.6615443871177882
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21146,167,2.21 [1.45-3.38],0.0002245991292747
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,2516,124,1.62 [1.02-2.59],0.0412982745997209
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,2678,319,1.59 [1.19-2.13],0.0015513947303296
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21081,102,1.26 [0.72-2.19],0.4144798755248021
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,2472,82,8.17 [4.74-14.09],4.0056150111009485e-14
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23155,2176,1.05 [0.93-1.18],0.430809763418184
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,23182,361,0.97 [0.72-1.29],0.8096236586441229
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21818,242,1.19 [0.84-1.69],0.3359346386580161
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,18077,805,1.26 [1.04-1.53],0.0206073646969578
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23818,253,1.48 [1.05-2.08],0.0256258694074505
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22709,271,0.83 [0.59-1.16],0.2780362723472499
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,21014,1508,0.94 [0.82-1.09],0.4249804244437222
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Aortic aneurysm,22821,383,0.79 [0.60-1.05],0.1050782391172321
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22522,84,1.34 [0.74-2.43],0.3333153771716572
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22686,248,1.13 [0.80-1.59],0.4990016095599286
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,14021,2324,0.96 [0.85-1.07],0.4425495068677548
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,AV-block,19255,622,1.08 [0.86-1.34],0.5257264745853487
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23869,540,1.49 [1.18-1.88],0.0008190018173896
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiac arrest,11950,253,1.27 [0.89-1.83],0.1918553187947591
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,18833,200,0.72 [0.48-1.06],0.096613644776284
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",18742,109,0.78 [0.46-1.33],0.3597798846039978
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23945,67,0.72 [0.37-1.38],0.3185766833182631
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,19999,1366,1.07 [0.92-1.24],0.3879250034446735
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22120,2637,0.93 [0.84-1.04],0.2054230437632119
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,20168,7799,0.88 [0.83-0.94],0.0001154417820475
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,22701,277,1.49 [1.07-2.06],0.0179043890331846
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Endocarditis,18717,84,1.01 [0.55-1.85],0.9843969998968892
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",23631,1333,0.99 [0.85-1.15],0.8451314887942525
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,21375,6798,0.87 [0.81-0.93],4.234076609941609e-05
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",21398,6821,0.88 [0.83-0.95],0.0003518737269426
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, portal",23712,111,1.29 [0.78-2.16],0.3247814210852063
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",14762,185,0.73 [0.50-1.08],0.1190482133373404
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,14746,169,14.00 [9.34-20.99],2.3423718534417338e-37
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,23797,1246,0.97 [0.83-1.13],0.706820612996911
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22864,118,0.99 [0.60-1.64],0.9696640114508616
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22261,2755,0.94 [0.84-1.04],0.2261868640750717
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23510,659,1.05 [0.84-1.29],0.6826070375170874
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Left bundle-branch block,19053,420,1.19 [0.91-1.56],0.2096697585812407
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23205,1068,1.06 [0.89-1.25],0.5163347284496432
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",20434,928,1.11 [0.93-1.33],0.2395365090093131
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23783,223,1.50 [1.04-2.15],0.0300533853055357
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23892,378,1.00 [0.75-1.32],0.9923585923714748
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Oesophageal varices,22495,71,1.82 [0.96-3.45],0.06618516113529
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other aneurysm,22534,96,1.20 [0.69-2.09],0.5249119918022039
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,19120,487,1.11 [0.86-1.43],0.4226014034383841
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22572,134,1.21 [0.76-1.94],0.4273051749010207
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22723,285,1.07 [0.78-1.48],0.6706067569919774
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,18831,198,0.99 [0.66-1.46],0.942277120687248
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other disorders of veins,22524,100,1.25 [0.73-2.14],0.4100207846457863
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,22475,51,1.12 [0.52-2.41],0.7767929020796307
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22345,91,0.55 [0.31-0.99],0.0463750499457551
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22533,109,0.80 [0.48-1.33],0.3859632494813061
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,19891,1258,1.00 [0.85-1.17],0.9922107420733955
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22617,66,3.78 [1.99-7.19],4.985743454245423e-05
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,23011,573,1.14 [0.91-1.43],0.2704313666405935
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,23295,365,0.79 [0.60-1.05],0.1107981808091588
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22928,674,1.13 [0.91-1.39],0.264632372076815
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,12076,379,0.93 [0.70-1.25],0.6454248663403794
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,22919,530,1.11 [0.88-1.41],0.3716452910282706
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22782,358,1.42 [1.06-1.90],0.0172193546311571
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,23432,502,0.97 [0.76-1.24],0.8090089288360703
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23881,717,0.94 [0.77-1.15],0.5571645232194733
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Right bundle-branch block,19104,471,1.15 [0.89-1.49],0.2741372432336663
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,23293,363,0.78 [0.59-1.04],0.0862844559175224
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22478,224,0.82 [0.57-1.18],0.2877649746938507
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23494,748,1.04 [0.85-1.27],0.7029828871235737
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23478,778,1.03 [0.84-1.25],0.7875244236385159
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22841,48,0.66 [0.30-1.47],0.3083365078531831
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22554,117,1.19 [0.71-1.98],0.5055320147985656
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,23104,253,1.03 [0.73-1.46],0.86427928068601
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22455,318,0.89 [0.66-1.21],0.4659958441087807
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,22810,386,0.97 [0.73-1.28],0.8099117092564649
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22456,76,1.18 [0.62-2.21],0.6165809841768246
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,23705,788,1.15 [0.95-1.40],0.1492293349762852
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23746,500,0.45 [0.35-0.58],2.2449708774252667e-10
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20579,971,0.84 [0.71-1.01],0.0637428074521202
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,23256,3648,0.86 [0.78-0.94],0.0009234066517351
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23683,590,0.42 [0.33-0.53],4.9539505743581296e-14
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20789,1181,0.83 [0.71-0.98],0.0245912118182851
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19691,83,0.70 [0.38-1.27],0.2398606652573141
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,23295,1537,0.83 [0.72-0.95],0.0084874910915308
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",21484,1876,0.74 [0.65-0.84],4.262568422701298e-06
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Vascular dementia,23433,152,1.20 [0.77-1.87],0.4205401602966895
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Alzheimer disease,23943,298,1.14 [0.83-1.57],0.4188781842691694
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",15909,58,2.00 [0.97-4.13],0.0619473876051982
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Bell's palsy,22566,76,0.91 [0.48-1.69],0.756832671366149
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22835,345,1.04 [0.77-1.39],0.8112162393976335
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral cysts,23536,239,0.86 [0.60-1.23],0.4053816747146178
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23858,368,0.69 [0.52-0.92],0.0124656025101805
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23429,58,0.72 [0.35-1.49],0.3725399064406931
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23924,73,1.14 [0.60-2.15],0.6954915923632379
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",23391,94,0.38 [0.22-0.67],0.0008270895692652
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,22323,288,0.67 [0.48-0.93],0.0160495291541482
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23406,1371,0.93 [0.80-1.08],0.3363078852232838
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23909,688,0.85 [0.69-1.05],0.1256733634009137
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,23393,2217,0.89 [0.80-1.00],0.0574637986428229
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Generalized epilepsy,23552,60,0.76 [0.37-1.56],0.4587431914467411
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,23773,283,0.82 [0.59-1.13],0.2303351068453617
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hydrocephalus,23353,56,0.56 [0.27-1.16],0.1199358059955956
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23927,61,0.84 [0.42-1.69],0.6263912700910941
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,22511,21,0.52 [0.16-1.75],0.2929769504264195
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,22583,93,0.76 [0.43-1.34],0.3357711927459334
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Memory loss,23270,121,1.04 [0.63-1.71],0.8850540496752994
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,22232,197,1.14 [0.77-1.70],0.5120749947626222
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23920,177,1.23 [0.81-1.86],0.3279679573258838
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Motor neuron disease,16016,152,0.72 [0.46-1.14],0.1626084189934141
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23831,64,0.88 [0.44-1.77],0.7267582955856523
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",23474,984,1.02 [0.85-1.21],0.8472590707787933
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,22624,3692,0.96 [0.88-1.05],0.4101860843012291
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23616,245,0.75 [0.53-1.07],0.1176502734299577
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",22883,393,1.03 [0.78-1.36],0.8244195314151062
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23849,355,1.34 [1.01-1.79],0.0450681137829582
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18778,626,0.93 [0.75-1.16],0.5299419221892816
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,23377,80,1.84 [1.00-3.37],0.0493014388974477
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other disorders of nervous system,23453,156,1.26 [0.81-1.94],0.3026652071411019
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23363,142,0.88 [0.56-1.40],0.5982207645815223
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other facial nerve disorders,22585,95,1.00 [0.57-1.74],0.986643742269112
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other headache syndromes,22073,38,1.12 [0.46-2.74],0.8085917928528369
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,23825,528,0.95 [0.75-1.21],0.7014363916866853
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,22740,705,0.98 [0.80-1.21],0.8589731150278679
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Parkinson's disease,23922,538,0.81 [0.64-1.03],0.0820360710167257
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,23324,27,1.86 [0.65-5.32],0.2446324224606847
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Restless leg syndrome,23944,52,0.92 [0.43-1.98],0.8404079092500066
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,23643,635,0.99 [0.80-1.23],0.9476776015283735
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Small fibre neuropathy,23552,58,1.12 [0.54-2.30],0.7654913717579481
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23926,178,0.71 [0.47-1.07],0.1028682105938322
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,22524,34,0.89 [0.35-2.28],0.8051013669358209
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23943,301,1.15 [0.84-1.58],0.3767165930452714
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),23402,148,1.19 [0.76-1.87],0.4379254549288229
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,23389,85,0.54 [0.30-0.98],0.0444433563413454
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23595,303,0.97 [0.70-1.33],0.8344446553380838
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23745,293,1.93 [1.41-2.63],3.633449745463928e-05
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,23065,44,0.45 [0.20-1.03],0.0583219942120122
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,23083,62,1.19 [0.59-2.38],0.6245267122514063
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23850,44,1.01 [0.45-2.28],0.9834348516231578
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23710,124,0.95 [0.58-1.55],0.8300709354027589
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",2476,84,7.46 [4.36-12.78],2.4684850679829014e-13
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,3014,132,1.51 [0.97-2.34],0.0667739938956748
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,23400,96,0.79 [0.45-1.38],0.4091887069403546
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23694,996,1.07 [0.90-1.27],0.4659267719976627
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23638,617,1.06 [0.85-1.32],0.6240400926486656
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,23165,144,1.08 [0.69-1.71],0.7285186115251538
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23869,577,1.12 [0.89-1.41],0.3186228449459723
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23941,66,1.13 [0.58-2.23],0.7132986253639432
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23799,507,1.09 [0.86-1.39],0.4786754429069935
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23905,319,0.93 [0.68-1.26],0.6226336108305446
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23855,150,0.78 [0.50-1.23],0.2858532666609646
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,23098,77,1.38 [0.74-2.55],0.3101547471309507
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,23107,86,1.09 [0.61-1.97],0.7699508339196507
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,23064,43,1.34 [0.59-3.04],0.4908911854490089
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23850,683,1.11 [0.90-1.37],0.3304816565475545
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,23349,182,1.17 [0.78-1.75],0.4478325047954176
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,23322,30,2.39 [0.90-6.36],0.0808017573703751
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23683,97,0.90 [0.52-1.57],0.7074582168943896
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23815,229,1.02 [0.71-1.47],0.8989354460885806
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,23464,172,1.16 [0.76-1.76],0.4981182797526596
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23788,83,0.53 [0.29-0.98],0.042619499688435
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23629,462,1.10 [0.85-1.42],0.4628726007881989
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,23434,130,0.84 [0.52-1.36],0.4864462656698611
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,22565,1803,1.12 [0.98-1.27],0.0910726156374205
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23784,198,0.94 [0.64-1.39],0.7602872306327217
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23928,149,1.22 [0.78-1.91],0.3732347747474231
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,23440,419,0.96 [0.73-1.25],0.7533690375306197
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23652,66,1.25 [0.64-2.44],0.5199930739547547
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23930,55,1.52 [0.73-3.17],0.2603462116838959
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,23099,78,0.78 [0.42-1.44],0.4199626579298483
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,23162,141,0.77 [0.49-1.22],0.2705393987979275
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22826,128,0.79 [0.49-1.29],0.3475948479319901
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,23344,52,1.64 [0.77-3.50],0.1981697770181195
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22763,65,0.45 [0.22-0.88],0.0207348356711609
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,23220,53,0.93 [0.44-1.98],0.8484197588207647
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",23375,208,1.34 [0.92-1.95],0.1286446108502414
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,23140,119,1.09 [0.66-1.79],0.7307683313007871
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22820,122,0.63 [0.38-1.04],0.0709284232050148
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22793,95,0.96 [0.55-1.69],0.8915417795524339
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,22240,1478,1.00 [0.87-1.16],0.9609400385653112
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,23079,58,0.73 [0.36-1.50],0.3962002246413725
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23696,392,0.81 [0.61-1.07],0.1376141501283949
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,23375,71,0.99 [0.52-1.90],0.9769549926506048
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),23472,168,1.14 [0.75-1.74],0.5350671856158351
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23767,58,1.54 [0.75-3.16],0.2352068135088143
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23901,122,1.02 [0.62-1.67],0.9417101044594922
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23809,114,1.01 [0.60-1.68],0.974811503086288
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23759,50,4.01 [1.90-8.44],0.0002592358097258
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23763,54,1.43 [0.68-3.00],0.3454770545715563
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23850,975,0.92 [0.77-1.09],0.3392530450663019
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23597,722,0.85 [0.69-1.05],0.1249302639245322
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,23005,130,1.19 [0.74-1.93],0.4672762972723041
RGMA,Repulsive guidance molecule A,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22961,86,1.71 [0.95-3.09],0.0727840216331853
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute pharyngitis,23731,62,1.21 [0.60-2.43],0.590936317999927
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23860,191,1.14 [0.77-1.70],0.5081632808654919
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23732,63,1.59 [0.81-3.12],0.1800083050415808
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza,21642,108,0.98 [0.58-1.67],0.9447347733939848
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),21639,105,0.96 [0.56-1.65],0.8841514753364398
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic asthma (mode),15700,107,1.22 [0.71-2.09],0.4793799746964557
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Allergic rhinitis,23836,267,0.89 [0.63-1.24],0.482045019911903
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",16693,1448,0.82 [0.70-0.95],0.0070990507721288
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",17014,1421,0.83 [0.71-0.96],0.0134665670533979
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23557,151,1.61 [1.04-2.51],0.0332811317353764
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21630,96,1.29 [0.74-2.27],0.3680556474441797
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Bronchiectasis,20818,296,0.63 [0.46-0.87],0.0047178254635168
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",20566,44,1.36 [0.60-3.08],0.4682151358349993
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,23094,2572,0.80 [0.71-0.89],3.740897009596097e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22494,80,0.62 [0.33-1.15],0.1299936827931057
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,22576,162,0.63 [0.41-0.97],0.0369097977228181
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23719,1310,0.68 [0.58-0.79],6.01166588330949e-07
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,22553,139,0.68 [0.43-1.09],0.1131159497126364
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21927,5305,0.84 [0.78-0.91],1.2121320582332398e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22809,395,0.70 [0.53-0.92],0.011984636997005
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,22717,308,0.58 [0.43-0.80],0.0008552671082764
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Emphysema,20869,347,0.79 [0.59-1.06],0.1166786551116548
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,23006,337,0.66 [0.48-0.89],0.0059975075830232
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,23694,2160,0.92 [0.82-1.04],0.1874280442172774
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,23035,366,0.65 [0.49-0.87],0.0039292304185642
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Later onset COPD,22869,1002,0.69 [0.58-0.83],4.007351694508041e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23926,429,1.12 [0.86-1.46],0.4019128199451097
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,22559,145,0.99 [0.63-1.57],0.9769111688882484
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23673,1008,0.92 [0.77-1.09],0.3380725134761852
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,23661,2211,0.83 [0.74-0.94],0.0022344860348975
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,23288,874,0.79 [0.65-0.95],0.0123263226673078
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other pleural conditions,21516,66,1.61 [0.82-3.15],0.1669613913246401
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23847,449,0.77 [0.59-0.99],0.0421129327158207
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23819,1399,0.85 [0.74-0.99],0.0313024986095319
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,22579,1129,0.91 [0.77-1.07],0.2377414345582089
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural plaque,21715,265,0.69 [0.49-0.97],0.0347616878531704
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23429,1895,0.86 [0.76-0.98],0.0237692860412566
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23825,328,1.42 [1.05-1.91],0.0231531740663751
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pneumothorax,21592,142,0.76 [0.47-1.21],0.2420792280377169
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pollen allergy,23928,233,0.88 [0.61-1.26],0.4855124925557527
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pulmonary oedema,23465,67,1.75 [0.91-3.36],0.0913577673780597
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Respiratory insufficiency,15648,55,0.51 [0.24-1.09],0.0830922995720588
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23655,990,0.92 [0.77-1.09],0.3263246464569951
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22683,269,0.88 [0.63-1.23],0.4608334634772999
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Viral pneumonia,21815,281,1.39 [1.00-1.93],0.0483794595797221
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23575,239,1.49 [1.05-2.12],0.0253074166086563
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,10431,117,0.44 [0.26-0.73],0.0018162083828423
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16737,91,1.05 [0.59-1.89],0.8659779023366199
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,23810,145,1.48 [0.94-2.34],0.0895828314523434
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute gastritis,18070,90,1.51 [0.85-2.67],0.1624471766331823
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,22585,205,1.02 [0.69-1.50],0.9226540618437976
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute peritonitis,23581,100,2.58 [1.51-4.39],0.0005175335886088
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23052,117,0.60 [0.36-1.00],0.0509991830191523
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Barrett oesophagus,18513,533,0.98 [0.77-1.25],0.8650171088879143
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",22501,121,1.31 [0.80-2.16],0.2846650607704267
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23541,121,1.32 [0.80-2.16],0.2750485585598741
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,22602,222,1.24 [0.86-1.80],0.2482354579253374
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,23168,788,1.12 [0.92-1.36],0.253970447093903
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,18246,266,0.97 [0.69-1.36],0.864443799549995
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic pancreatitis,22437,57,0.65 [0.31-1.35],0.2483919991303171
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23736,135,1.53 [0.97-2.42],0.0700699887099187
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,22299,93,1.07 [0.61-1.91],0.8055721609701492
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Collagenous colitis,22500,50,1.47 [0.67-3.19],0.3348702791941588
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23779,223,0.93 [0.64-1.34],0.6930915295777162
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,23779,1604,1.04 [0.90-1.19],0.6008882154903801
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,22541,91,1.38 [0.77-2.45],0.2793563544495121
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23603,65,1.10 [0.56-2.18],0.7763016732887524
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,22527,77,2.24 [1.20-4.17],0.0108580638866786
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,23291,225,1.08 [0.75-1.56],0.662790943759833
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,20271,1956,0.94 [0.83-1.07],0.3393257105421179
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,23842,177,1.50 [0.99-2.26],0.0544133195291877
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,23805,870,0.98 [0.81-1.18],0.8127903629562084
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21942,3962,1.00 [0.92-1.09],0.971895328439335
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23578,512,1.24 [0.98-1.58],0.0764889523711346
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,23894,413,1.18 [0.90-1.55],0.2210783256999094
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,23175,109,1.24 [0.73-2.09],0.4275850869840871
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of salivary glands,23033,65,0.99 [0.50-1.95],0.9685916296945428
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,23625,1419,0.94 [0.81-1.08],0.3663331374504214
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of tongue,23054,108,1.74 [1.03-2.94],0.0376777371782879
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",23576,1196,1.12 [0.96-1.31],0.1555555478926872
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19709,3063,0.92 [0.84-1.02],0.1205897621720367
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,18249,269,1.12 [0.80-1.57],0.4982726951925601
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23829,211,0.98 [0.67-1.43],0.9149262863254262
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23868,47,1.49 [0.67-3.32],0.3262795247569156
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23093,158,1.73 [1.13-2.65],0.0114117930090216
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16827,181,1.07 [0.71-1.62],0.7357869386825084
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,18410,430,1.00 [0.77-1.31],0.9962757240709368
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,18350,370,1.06 [0.79-1.40],0.711665257091658
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,20147,2167,0.93 [0.83-1.05],0.262235250136463
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,18583,603,1.02 [0.82-1.28],0.8591724848516598
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18311,8026,0.95 [0.89-1.01],0.1155841318533507
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,23386,1180,0.91 [0.78-1.07],0.2405240846682242
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,23109,43,0.81 [0.35-1.88],0.6261381314632453
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17609,1234,1.01 [0.86-1.18],0.928217108126975
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23019,84,1.36 [0.75-2.47],0.3056180163938539
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,21879,3564,0.89 [0.81-0.97],0.0100936712636702
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,23871,44,1.20 [0.52-2.75],0.6640376290337917
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impaction of intestines,16693,47,0.83 [0.37-1.88],0.6590104966326051
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,19963,1648,0.81 [0.71-0.93],0.0028173791290893
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Inguinal hernia, bilateral",18515,200,0.79 [0.53-1.18],0.2476959674892437
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16736,90,2.24 [1.25-4.01],0.0065513024585032
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,22312,106,1.08 [0.63-1.84],0.790226555864874
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,16920,274,1.22 [0.87-1.71],0.2500308121406968
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23904,377,1.05 [0.79-1.39],0.7308886725392524
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,23132,682,1.22 [0.99-1.51],0.0616944928052316
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,23341,891,1.04 [0.87-1.25],0.6625684618686631
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,18194,214,0.90 [0.62-1.32],0.5960793082385645
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,18613,633,1.11 [0.89-1.38],0.353079330751968
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23891,113,0.87 [0.52-1.46],0.602442245504225
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,18393,78,1.31 [0.70-2.43],0.3984018873647521
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,18076,1430,0.96 [0.83-1.11],0.5854877884091566
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,22639,259,1.26 [0.89-1.77],0.190620298869976
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,22504,124,1.32 [0.81-2.17],0.2646822532300459
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,18522,1876,0.95 [0.83-1.08],0.4016590445986755
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,22132,5486,1.00 [0.92-1.07],0.9099149714628788
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,23016,179,1.05 [0.70-1.59],0.8132731082468361
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,23630,695,1.07 [0.87-1.31],0.526940255126874
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18723,743,0.98 [0.80-1.21],0.8800011008692528
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of pancreas,22524,144,1.63 [1.03-2.57],0.0352968010156087
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23821,340,0.95 [0.70-1.27],0.7142246610456382
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18783,803,1.17 [0.96-1.42],0.1167250684642751
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,23398,1192,0.91 [0.78-1.07],0.2471824729119763
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,23245,179,1.23 [0.82-1.85],0.3202788899500137
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18288,1642,1.03 [0.90-1.18],0.687687817976705
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19867,1887,1.02 [0.90-1.15],0.8018778028010676
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23033,98,1.02 [0.59-1.77],0.9377624686596624
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,23232,782,1.23 [1.01-1.49],0.0410308635552192
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17000,354,0.83 [0.62-1.12],0.2308667246800967
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23859,57,1.85 [0.90-3.80],0.095769109655269
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17125,479,1.02 [0.79-1.32],0.8660031426819038
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22372,166,1.23 [0.80-1.88],0.3389253549084881
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Recurring oral aphthae,23930,42,1.08 [0.47-2.52],0.849993058344283
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,23074,106,1.19 [0.69-2.03],0.5309783980524532
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Toxic colitis,22496,46,1.31 [0.58-2.93],0.5184511255668598
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,18280,300,0.92 [0.67-1.26],0.5919901866260773
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,22597,147,0.85 [0.54-1.35],0.4916871996496224
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",22574,124,0.83 [0.50-1.36],0.4600597332359121
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,18689,374,0.96 [0.72-1.28],0.7985560401578501
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16805,159,0.96 [0.61-1.49],0.8482444075645186
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,18580,265,0.85 [0.60-1.19],0.3382959295784838
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Volvulus,16720,74,1.35 [0.70-2.57],0.3685963235081509
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23870,335,1.16 [0.86-1.57],0.3277659201607962
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23622,67,0.70 [0.36-1.36],0.2928693694552383
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21938,98,1.17 [0.67-2.05],0.5788988214847712
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,23205,766,1.02 [0.84-1.24],0.8569969744972251
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22641,202,1.04 [0.71-1.54],0.8274218413751497
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,22316,476,1.04 [0.81-1.33],0.7639234303545875
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23650,271,0.81 [0.58-1.14],0.2256044469423431
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23854,475,0.82 [0.64-1.06],0.1315930631535619
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,23424,45,0.44 [0.19-1.00],0.0503047793245755
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22456,3200,1.00 [0.90-1.10],0.9390816254053628
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23495,409,0.74 [0.57-0.98],0.0330728527909432
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,23381,295,0.80 [0.58-1.10],0.1674177917608443
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23480,1041,1.02 [0.86-1.21],0.7913317209732948
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23934,30,0.85 [0.31-2.31],0.7488192875880102
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21863,23,1.10 [0.35-3.47],0.8678479161486611
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,23144,58,1.06 [0.52-2.15],0.8658504497786702
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23645,266,0.82 [0.58-1.14],0.2406471892852043
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,22326,486,1.24 [0.96-1.59],0.0971993386082547
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21920,80,0.95 [0.51-1.76],0.8630418056001301
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23877,82,1.47 [0.81-2.67],0.2103944618592768
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22659,220,0.93 [0.64-1.34],0.7020924706056685
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23774,219,0.76 [0.52-1.10],0.1504158409080928
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,23450,71,1.38 [0.72-2.62],0.3295672288377497
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21907,67,1.72 [0.88-3.36],0.1118165765220161
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,23488,1648,1.05 [0.91-1.20],0.5220874339805015
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",22367,527,1.19 [0.94-1.52],0.1474454473329575
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21923,83,0.94 [0.51-1.72],0.8340559534345093
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23853,298,0.77 [0.56-1.06],0.1068634885399441
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23433,54,1.08 [0.52-2.27],0.8343373689295195
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23817,262,0.78 [0.56-1.10],0.1524237564887802
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23889,354,1.22 [0.91-1.63],0.1823241332728721
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21931,91,1.21 [0.68-2.15],0.5269825017700362
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,22111,271,0.77 [0.55-1.08],0.1292432239840554
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23882,347,1.20 [0.89-1.61],0.2252152365163073
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",22114,274,1.00 [0.72-1.39],0.9986963544017344
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23919,124,1.55 [0.95-2.52],0.0771530161563076
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,20670,92,1.27 [0.72-2.25],0.4060246617310131
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21834,4797,0.98 [0.91-1.06],0.6623888900654603
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20428,3391,1.00 [0.91-1.10],0.991608781182255
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,20651,73,0.38 [0.20-0.72],0.003158801649636
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,21021,153,1.24 [0.79-1.92],0.3487539846984967
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,21013,145,1.42 [0.90-2.24],0.1267120343179662
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23740,68,2.01 [1.04-3.87],0.0373833705050196
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20947,79,0.90 [0.48-1.69],0.7458040165420712
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17910,873,0.92 [0.76-1.11],0.3661036061292809
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23825,151,1.08 [0.70-1.69],0.7239436522233289
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,21142,274,0.91 [0.65-1.27],0.5742978380684938
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,20354,6274,0.91 [0.85-0.98],0.0104915455156302
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,22873,92,0.65 [0.37-1.15],0.1413348692405676
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20745,167,0.80 [0.52-1.23],0.3093623254506151
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,21016,438,0.98 [0.76-1.28],0.9065116132660134
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,23112,2244,0.96 [0.85-1.07],0.4422015859834058
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20945,367,0.90 [0.67-1.20],0.4634923567329887
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20632,54,1.09 [0.51-2.31],0.8230795866087933
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20672,94,0.95 [0.54-1.69],0.8679874357114649
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,23623,30,0.77 [0.29-2.09],0.613368069727976
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,18511,1474,0.98 [0.85-1.13],0.8058557868174401
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18019,982,1.05 [0.89-1.25],0.552385275614527
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23803,968,1.02 [0.86-1.22],0.7839944073513201
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,17086,49,1.01 [0.46-2.25],0.9772334950860716
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),17117,80,1.22 [0.66-2.27],0.5297826282376504
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20850,272,0.68 [0.48-0.95],0.0242356689601547
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,17671,634,1.25 [1.00-1.55],0.0506404319028807
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20911,43,0.83 [0.36-1.94],0.6722348860643168
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,21400,532,1.05 [0.82-1.33],0.7147768727952051
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,21139,271,1.03 [0.74-1.44],0.8677803087520737
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,17629,592,1.30 [1.04-1.64],0.0222504736569982
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,20644,66,0.81 [0.41-1.59],0.5359062507594509
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",20632,54,1.27 [0.60-2.69],0.5242962964889591
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,22877,96,1.40 [0.81-2.40],0.2279465925012382
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23651,870,0.98 [0.81-1.18],0.8258495586668744
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,23185,404,1.07 [0.82-1.41],0.605489957769876
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23860,289,1.02 [0.74-1.41],0.8859113695995852
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18932,1895,0.99 [0.87-1.13],0.8847075830025938
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,17089,52,1.07 [0.49-2.33],0.8663010322653175
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,20660,82,1.09 [0.59-2.00],0.7928262103705174
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,17092,55,1.62 [0.77-3.41],0.2020807308707227
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),17083,46,1.69 [0.75-3.81],0.2054067228120785
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,22967,186,0.99 [0.67-1.49],0.978255499469804
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,22943,162,1.03 [0.67-1.58],0.9001138500314566
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23909,86,0.85 [0.47-1.53],0.5779197246411056
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",22405,1537,1.05 [0.91-1.21],0.4955101600395364
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,20646,68,1.44 [0.74-2.82],0.2841287210028119
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),17077,40,0.55 [0.22-1.34],0.1855053962112641
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,21491,623,1.02 [0.82-1.27],0.8417584779867193
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18759,1722,1.04 [0.91-1.19],0.5258108142922899
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,23647,54,0.99 [0.47-2.07],0.9711592742662324
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23926,61,0.64 [0.32-1.28],0.2089483586068485
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,20659,81,0.51 [0.28-0.95],0.0335668589899071
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21568,990,0.98 [0.82-1.17],0.8125146946296591
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,20674,96,1.01 [0.57-1.77],0.9778747297071412
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,18246,1209,0.85 [0.72-0.99],0.0402895195772361
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,22866,85,0.86 [0.48-1.57],0.6339642325801061
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,20623,45,2.55 [1.12-5.81],0.0253839520438747
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20980,112,0.70 [0.42-1.17],0.1696685495566743
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,21082,504,0.97 [0.76-1.24],0.8196549922749009
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,23789,196,0.95 [0.64-1.40],0.7868641338124387
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,21354,486,0.94 [0.73-1.20],0.5985926880743306
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23869,283,1.07 [0.77-1.47],0.7012899353505433
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23929,39,0.85 [0.35-2.04],0.7155678644226924
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20731,153,0.83 [0.53-1.30],0.4147003024998101
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,19630,582,1.13 [0.90-1.42],0.2855181539831996
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,21063,485,1.04 [0.81-1.34],0.7503400297281889
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],20910,332,0.85 [0.63-1.16],0.3025151436220417
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",17068,31,0.78 [0.29-2.14],0.6329328254832343
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,19309,2272,0.89 [0.79-1.00],0.0520955288013826
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,17494,457,1.15 [0.89-1.49],0.290100867375423
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,23758,165,0.84 [0.54-1.28],0.4129087576082902
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23871,48,1.10 [0.50-2.42],0.8202837352296106
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21940,46,2.36 [1.08-5.14],0.0303711176615432
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,17100,63,0.63 [0.31-1.28],0.2054102288214097
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20957,89,1.20 [0.67-2.16],0.5311741572941079
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,17334,297,0.98 [0.71-1.35],0.9071116535451133
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20858,280,0.69 [0.49-0.95],0.0252773160797407
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,21086,218,1.15 [0.79-1.66],0.4678386623683264
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20963,95,1.16 [0.66-2.04],0.5995047873966183
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,19011,31,0.40 [0.15-1.11],0.0787599063856043
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23930,40,0.92 [0.39-2.17],0.8428477913746381
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,21111,533,0.71 [0.56-0.91],0.0056275452035314
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],23614,21,1.56 [0.49-5.02],0.4544236104618478
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22859,2281,0.93 [0.83-1.05],0.2503186215033423
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20683,105,0.75 [0.44-1.29],0.3006905780655562
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,21376,508,1.06 [0.83-1.35],0.6449357416943795
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,22879,197,0.78 [0.53-1.15],0.2103243474166681
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20998,130,0.98 [0.61-1.58],0.939097578585451
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,22186,1318,0.98 [0.85-1.14],0.8328403639395693
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,21693,825,1.02 [0.84-1.23],0.8423427169099791
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],20621,43,1.02 [0.44-2.38],0.9643878736688588
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,23631,38,0.49 [0.20-1.20],0.1210534957640597
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20699,121,0.87 [0.52-1.43],0.5788950466895743
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20600,22,1.91 [0.60-6.05],0.2697833081231162
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),17097,60,0.98 [0.48-2.01],0.9487486325430216
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,22938,1883,1.68 [1.48-1.91],1.525747664645852e-15
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23470,412,0.84 [0.64-1.10],0.2145513470601815
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23200,142,0.73 [0.46-1.15],0.1730443392620016
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22602,1547,4.06 [3.54-4.66],1.5165825377533077e-89
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23692,85,19.13 [11.42-32.05],3.620791301036114e-29
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23665,359,1.36 [1.02-1.81],0.0384437514671599
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,21053,212,1.07 [0.73-1.56],0.7368739753475451
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dialysis,21157,102,39.88 [25.21-63.09],7.038036906830575e-56
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,22659,3341,0.99 [0.90-1.09],0.8379866260446542
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21569,5622,1.18 [1.10-1.27],9.893918033385166e-06
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23710,103,7.60 [4.64-12.44],7.392051272560341e-16
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,19526,208,0.67 [0.46-0.99],0.0432757694741547
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21164,373,1.58 [1.18-2.12],0.0019225435890951
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,21943,2625,0.99 [0.89-1.10],0.860559697361599
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19552,234,0.83 [0.58-1.19],0.3085835113895742
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20920,79,1.50 [0.81-2.77],0.2012636092626081
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Orchitis and epididymitis,19426,108,0.71 [0.42-1.20],0.1983853222638616
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23932,62,1.42 [0.71-2.81],0.3215671586064185
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23938,57,0.62 [0.30-1.29],0.2038836037829877
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,23103,2262,1.05 [0.93-1.18],0.4348582916274607
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,21799,958,1.02 [0.85-1.21],0.8649516189090748
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23871,565,1.82 [1.45-2.29],2.450271095252504e-07
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19629,311,1.05 [0.77-1.44],0.7562625932357399
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19600,282,0.90 [0.65-1.25],0.5171970502911132
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of prostate,19553,235,0.91 [0.64-1.30],0.6089019607545365
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23928,46,0.92 [0.41-2.05],0.8316190178337242
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22386,1545,1.12 [0.98-1.29],0.1017310902957986
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21209,418,1.69 [1.29-2.23],0.0001642330702895
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23497,191,2.70 [1.83-3.98],5.623254396633346e-07
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23667,60,3.29 [1.64-6.60],0.0008138600861565
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19585,267,1.04 [0.74-1.45],0.8396946386037641
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23640,2849,1.93 [1.74-2.14],1.8281105042166293e-35
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",20865,74,1.92 [1.00-3.68],0.0484666295157959
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21213,158,2.73 [1.75-4.25],9.114298273215334e-06
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23137,79,1.41 [0.76-2.61],0.2719950288788768
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,21136,295,1.25 [0.91-1.72],0.1702468801971774
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,23589,531,0.85 [0.67-1.08],0.1811525239312904
